{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:29:45Z","timestamp":1763728185119,"version":"build-2065373602"},"reference-count":96,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Minist\u00e8re de l\u2019Education Nationale de la Recherche et de la Technologie, Universit\u00e9 de Lille","award":["ULR3610"],"award-info":[{"award-number":["ULR3610"]}]},{"name":"Centre Hospitalier et Universitaire de Lille","award":["none"],"award-info":[{"award-number":["none"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Enteroviruses (EVs), especially coxsackieviruses B (CVB), are believed to trigger or accelerate islet autoimmunity in genetically susceptible individuals that results in type 1 diabetes (T1D). Therefore, strategies are needed to fight against EV infections. There are no approved antiviral drugs currently available, but various antiviral drugs targeting viral or host cell proteins and vaccines have recently shown potential to combat CVB infections and may be used as new therapeutic strategies to prevent or reduce the risk of T1D and\/or preserve \u03b2-cell function among patients with islet autoantibodies or T1D.<\/jats:p>","DOI":"10.3390\/microorganisms10040768","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T21:23:55Z","timestamp":1648848235000},"page":"768","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Fighting Enteroviral Infections to Prevent Type 1 Diabetes"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2981-0803","authenticated-orcid":false,"given":"Magloire Pandoua","family":"Nekoua","sequence":"first","affiliation":[{"name":"Laboratoire de Virologie ULR3610, Universit\u00e9 de Lille, CHU Lille, 59000 Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7926-6167","authenticated-orcid":false,"given":"Ambroise","family":"Mercier","sequence":"additional","affiliation":[{"name":"Laboratoire de Virologie ULR3610, Universit\u00e9 de Lille, CHU Lille, 59000 Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4260-6540","authenticated-orcid":false,"given":"Abdulaziz","family":"Alhazmi","sequence":"additional","affiliation":[{"name":"Laboratoire de Virologie ULR3610, Universit\u00e9 de Lille, CHU Lille, 59000 Lille, France"},{"name":"Microbiology and Parasitology Department, College of Medicine, Jazan University, Jazan 82911, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Famara","family":"Sane","sequence":"additional","affiliation":[{"name":"Laboratoire de Virologie ULR3610, Universit\u00e9 de Lille, CHU Lille, 59000 Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1106-9826","authenticated-orcid":false,"given":"Enagnon Kazali","family":"Alidjinou","sequence":"additional","affiliation":[{"name":"Laboratoire de Virologie ULR3610, Universit\u00e9 de Lille, CHU Lille, 59000 Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4301-2074","authenticated-orcid":false,"given":"Didier","family":"Hober","sequence":"additional","affiliation":[{"name":"Laboratoire de Virologie ULR3610, Universit\u00e9 de Lille, CHU Lille, 59000 Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1099\/jgv.0.000911","article-title":"ICTV Virus Taxonomy Profile: Picornaviridae","volume":"98","author":"Zell","year":"2017","journal-title":"J. Gen. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00705-019-04520-6","article-title":"Recommendations for the nomenclature of enteroviruses and rhinoviruses","volume":"165","author":"Simmonds","year":"2020","journal-title":"Arch. Virol."},{"key":"ref_3","unstructured":"DM, K., and Howley, P. (2013). Enteroviruses: Polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. Fields Virology, Lippincott Williams & Wilkins."},{"key":"ref_4","first-page":"273","article-title":"Enterovirus persistence as a mechanism in the pathogenesis of type 1 diabetes","volume":"18","author":"Alidjinou","year":"2014","journal-title":"Discov. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1080\/21505594.2017.1308620","article-title":"Acute and chronic disease caused by enteroviruses","volume":"8","author":"Tang","year":"2017","journal-title":"Virulence"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jmii.2019.08.018","article-title":"Enteroviral infection in neonates","volume":"52","author":"Chuang","year":"2019","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrendo.2010.27","article-title":"Pathogenesis of type 1 diabetes mellitus: Interplay between enterovirus and host","volume":"6","author":"Hober","year":"2010","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Isaacs, S.R., Foskett, D.B., Maxwell, A.J., Ward, E.J., Faulkner, C.L., Luo, J.Y.X., Rawlinson, W.D., Craig, M.E., and Kim, K.W. (2021). Viruses and Type 1 Diabetes: From Enteroviruses to the Virome. Microorganisms, 9.","DOI":"10.20944\/preprints202106.0574.v1"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Brown, D.M., Zhang, Y., and Scheuermann, R.H. (2020). Epidemiology and Sequence-Based Evolutionary Analysis of Circulating Non-Polio Enteroviruses. Microorganisms, 8.","DOI":"10.3390\/microorganisms8121856"},{"key":"ref_10","first-page":"67","article-title":"The coxsackievirus and adenovirus receptor","volume":"323","author":"Freimuth","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41579-018-0005-4","article-title":"The life cycle of non-polio enteroviruses and how to target it","volume":"16","author":"Baggen","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.micro.56.012302.160757","article-title":"Poliovirus Cell Entry: Common Structural Themes in Viral Cell Entry Pathways","volume":"56","author":"Hogle","year":"2002","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.3390\/v7082832","article-title":"Replication and Inhibitors of Enteroviruses and Parechoviruses","volume":"7","author":"Wolthers","year":"2015","journal-title":"Viruses"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1086\/375069","article-title":"Efficacy and Safety of Oral Pleconaril for Treatment of Colds Due to Picornaviruses in Adults: Results of 2 Double-Blind, Randomized, Placebo-Controlled Trials","volume":"36","author":"Hayden","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1473-3099(02)00277-3","article-title":"FDA panel rejects common cold treatment","volume":"2","author":"Senior","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1128\/AAC.43.9.2109","article-title":"Activity of Pleconaril against Enteroviruses","volume":"43","author":"Pevear","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.antiviral.2008.09.002","article-title":"New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3","volume":"81","author":"Schmidtke","year":"2009","journal-title":"Antivir. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1016\/j.jmb.2013.10.008","article-title":"Serum-Dependent Enhancement of Coxsackievirus B4-Induced Production of IFN\u03b1, IL-6 and TNF\u03b1 by Peripheral Blood Mononuclear Cells","volume":"425","author":"Alidjinou","year":"2013","journal-title":"J. Mol. Biol."},{"key":"ref_19","first-page":"1849","article-title":"A preclinical assessment to repurpose drugs to target type 1 diabetes-associated type B coxsackieviruses","volume":"37","author":"Honkimaa","year":"2019","journal-title":"Diabet. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection","volume":"347","author":"Fried","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/tid.12194","article-title":"Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients","volume":"16","author":"Marcelin","year":"2014","journal-title":"Transpl. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/82191","article-title":"The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen","volume":"6","author":"Crotty","year":"2000","journal-title":"Nat. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0166-3542(97)01028-0","article-title":"Inhibition of coxsackievirus B3 carrier state infection of cultured human myocardial fibroblasts by ribavirin and human natural interferon-\u03b1","volume":"34","author":"Heim","year":"1997","journal-title":"Antivir. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3389\/fmicb.2020.01105","article-title":"Remdesivir (GS-5734) Impedes Enterovirus Replication Through Viral RNA Synthesis Inhibition","volume":"11","author":"Ye","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00063198-200405000-00009","article-title":"Antiviral chemotherapeutic agents against respiratory viruses: Where are we now and what\u2019s in the pipeline?","volume":"10","author":"Brooks","year":"2004","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00705-009-0346-4","article-title":"Antiviral activity of Arbidol against Coxsackie virus B5 in vitro and in vivo","volume":"154","author":"Zhong","year":"2009","journal-title":"Arch. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1128\/AAC.00983-12","article-title":"Fluoxetine Is a Potent Inhibitor of Coxsackievirus Replication","volume":"56","author":"Zuo","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1128\/AAC.02182-15","article-title":"Screening of a Library of FDA-Approved Drugs Identifies Several Enterovirus Replication Inhibitors That Target Viral Protein 2C","volume":"60","author":"Ulferts","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"104781","DOI":"10.1016\/j.antiviral.2020.104781","article-title":"Synthesis and antiviral effect of novel fluoxetine analogues as enterovirus 2C inhibitors","volume":"178","author":"Manganaro","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1128\/AAC.05108-14","article-title":"Discovery of Itraconazole with Broad-Spectrum In Vitro Antienterovirus Activity That Targets Nonstructural Protein 3A","volume":"59","author":"Gao","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"104650","DOI":"10.1016\/j.antiviral.2019.104650","article-title":"Emetine protects mice from enterovirus infection by inhibiting viral translation","volume":"173","author":"Tang","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.antiviral.2015.01.010","article-title":"Persistent infection of human pancreatic cells with Coxsackievirus B4 is cured by fluoxetine","volume":"116","author":"Alidjinou","year":"2015","journal-title":"Antivir. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.antiviral.2018.10.002","article-title":"Fluoxetine can inhibit coxsackievirus-B4 E2 in vitro and in vivo","volume":"159","author":"Benkahla","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"104334","DOI":"10.1016\/j.jcv.2020.104334","article-title":"Eradication of persistent coxsackievirus B infection from a pancreatic cell line with clinically used antiviral drugs","volume":"128","author":"Honkimaa","year":"2020","journal-title":"J. Clin. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Alidjinou, E.K., Bertin, A., Sane, F., Caloone, D., Engelmann, I., and Hober, D. (2019). Emergence of Fluoxetine-Resistant Variants during Treatment of Human Pancreatic Cell Cultures Persistently Infected with Coxsackievirus B4. Viruses, 11.","DOI":"10.3390\/v11060486"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Abdelnabi, R., Geraets, J.A., Ma, Y., Mirabelli, C., Flatt, J.W., Domanska, A., Delang, L., Jochmans, D., Kumar, T.A., and Jayaprakash, V. (2019). A novel druggable interprotomer pocket in the capsid of rhino- and enteroviruses. PLoS Biol., 17.","DOI":"10.1371\/journal.pbio.3000281"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cell.2010.03.050","article-title":"Viral Reorganization of the Secretory Pathway Generates Distinct Organelles for RNA Replication","volume":"141","author":"Hsu","year":"2010","journal-title":"Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/cr.2012.129","article-title":"Coxsackievirus mutants that can bypass host factor PI4KIII\u03b2 and the need for high levels of PI4P lipids for replication","volume":"22","author":"Lanke","year":"2012","journal-title":"Cell Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.celrep.2014.12.054","article-title":"Itraconazole Inhibits Enterovirus Replication by Targeting the Oxysterol-Binding Protein","volume":"10","author":"Strating","year":"2015","journal-title":"Cell Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.antiviral.2018.05.010","article-title":"Structure-activity relationship study of itraconazole, a broad-range inhibitor of picornavirus replication that targets oxysterol-binding protein (OSBP)","volume":"156","author":"Bauer","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1128\/JVI.01374-07","article-title":"Amiloride Derivatives Inhibit Coxsackievirus B3 RNA Replication","volume":"82","author":"Harrison","year":"2008","journal-title":"J. Virol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"7535","DOI":"10.1128\/JVI.02684-09","article-title":"Differential Effects of the Putative GBF1 Inhibitors Golgicide A and AG1478 on Enterovirus Replication","volume":"84","author":"Lanke","year":"2010","journal-title":"J. Virol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1101\/gad.1505307","article-title":"Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance","volume":"21","author":"Geller","year":"2007","journal-title":"Genes Dev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.biologicals.2016.08.005","article-title":"Development of inactivated poliovirus vaccine from Sabin strains: A progress report","volume":"44","author":"Okayasu","year":"2016","journal-title":"Biologicals"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1080\/21645515.2018.1442997","article-title":"Five-year immunity persistence following immunization with inactivated enterovirus 71 type (EV71) vaccine in healthy children: A further observation","volume":"14","author":"Hu","year":"2018","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s00125-017-4492-z","article-title":"A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes","volume":"61","author":"Stone","year":"2018","journal-title":"Diabetologia"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"eaaz2433","DOI":"10.1126\/sciadv.aaz2433","article-title":"A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates","volume":"6","author":"Stone","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_48","unstructured":"(2021, December 07). PROtocol for Coxsackievirus VaccinE in Healthy VoluNTteers\u2014Full Text View\u2014ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04690426?term=NCT04690426&draw=2&rank=1."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.antiviral.2014.01.013","article-title":"Coxsackievirus B3 VLPs purified by ion exchange chromatography elicit strong immune responses in mice","volume":"104","author":"Koho","year":"2014","journal-title":"Antivir. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"104595","DOI":"10.1016\/j.antiviral.2019.104595","article-title":"Formalin treatment increases the stability and immunogenicity of coxsackievirus B1 VLP vaccine","volume":"171","author":"Hankaniemi","year":"2019","journal-title":"Antivir. Res."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Hankaniemi, M.M., Baikoghli, M.A., Stone, V.M., Xing, L., V\u00e4\u00e4t\u00e4inen, O., Soppela, S., Sioofy-Khojine, A., Saarinen, N.V.V., Ou, T., and Anson, B. (2020). Structural Insight into CVB3-VLP Non-Adjuvanted Vaccine. Microorganisms, 8.","DOI":"10.3390\/microorganisms8091287"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1007\/s11033-020-05333-6","article-title":"Characterization of Coxsackievirus B4 virus-like particles VLP produced by the recombinant baculovirus-insect cell system expressing the major capsid protein","volume":"47","author":"Hassine","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"98","DOI":"10.34172\/hpp.2020.18","article-title":"Prevalence and incidence of type 1 diabetes in the world: A systematic review and meta-analysis","volume":"10","author":"Mobasseri","year":"2020","journal-title":"Heal. Promot. Perspect."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"107842","DOI":"10.1016\/j.diabres.2019.107842","article-title":"Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"157","author":"Patterson","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1007\/s00125-021-05568-3","article-title":"The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"64","author":"Holt","year":"2021","journal-title":"Diabetologia"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41574-019-0254-y","article-title":"The heterogeneous pathogenesis of type 1 diabetes mellitus","volume":"15","author":"Ilonen","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2337\/diabetes.51.6.1964","article-title":"Enterovirus RNA Is Found in Peripheral Blood Mononuclear Cells in a Majority of Type 1 Diabetic Children at Onset","volume":"51","author":"Yin","year":"2002","journal-title":"Diabetes"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1073\/pnas.0700442104","article-title":"Coxsackie B4 virus infection of \u03b2 cells and natural killer cell insulitis in recent-onset type 1 diabetic patients","volume":"104","author":"Dotta","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00125-009-1276-0","article-title":"The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes","volume":"52","author":"Richardson","year":"2009","journal-title":"Diabetologia"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2337\/db10-0186","article-title":"Enterovirus RNA in Blood Is Linked to the Development of Type 1 Diabetes","volume":"60","author":"Oikarinen","year":"2011","journal-title":"Diabetes"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2337\/db11-1157","article-title":"Type 1 Diabetes Is Associated with Enterovirus Infection in Gut Mucosa","volume":"61","author":"Oikarinen","year":"2012","journal-title":"Diabetes"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/eci.12485","article-title":"Monocytes of Patients with Type 1 Diabetes Harbour Enterovirus RNA","volume":"45","author":"Alidjinou","year":"2015","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.2337\/db14-1370","article-title":"Detection of a Low-Grade Enteroviral Infection in the Islets of Langerhans of Living Patients Newly Diagnosed with Type 1 Diabetes","volume":"64","author":"Krogvold","year":"2015","journal-title":"Diabetes"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e2916","DOI":"10.1002\/dmrr.2916","article-title":"Marker of coxsackievirus-B4 infection in saliva of patients with type 1 diabetes","volume":"33","author":"Sane","year":"2017","journal-title":"Diabetes\/Metab. Res. Rev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"d35","DOI":"10.1136\/bmj.d35","article-title":"Enterovirus infection and type 1 diabetes mellitus: Systematic review and meta-analysis of observational molecular studies","volume":"342","author":"Yeung","year":"2011","journal-title":"BMJ"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"706964","DOI":"10.3389\/fendo.2021.706964","article-title":"Association Between Enterovirus Infection and Type 1 Diabetes Risk: A Meta-Analysis of 38 Case-Control Studies","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Alhazmi, A., Nekoua, M., Michaux, H., Sane, F., Halouani, A., Engelmann, I., Alidjinou, E., Martens, H., Jaidane, H., and Geenen, V. (2021). Effect of Coxsackievirus B4 Infection on the Thymus: Elucidating Its Role in the Pathogenesis of Type 1 Diabetes. Microorganisms, 9.","DOI":"10.3390\/microorganisms9061177"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/pedi.12370","article-title":"Viruses in type 1 diabetes","volume":"17","year":"2016","journal-title":"Pediatr. Diabetes"},{"key":"ref_69","unstructured":"(2021, December 07). The Diabetes Virus Detection and Intervention Trial\u2014Full Text View\u2014ClinicalTrials.gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04838145?term=2015-003350-41&draw=2&rank=1."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijantimicag.2017.03.010","article-title":"Bifidobacteria-derived lipoproteins inhibit infection with coxsackievirus B4 in vitro","volume":"50","author":"Romond","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.micres.2018.03.008","article-title":"Inhibition of coxsackievirus B4 by Lactobacillus plantarum","volume":"210","author":"Arena","year":"2018","journal-title":"Microbiol. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"5697571","DOI":"10.1155\/2016\/5697571","article-title":"Efficacy of Scutellaria baicalensis for the Treatment of Hand, Foot, and Mouth Disease Associated with Encephalitis in Patients Infected with EV71: A Multicenter, Retrospective Analysis","volume":"2016","author":"Lin","year":"2016","journal-title":"BioMed Res. Int."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/jmv.25436","article-title":"Aqueous extracts of Syzygium brazzavillense can inhibit the infection with coxsackievirus B4 in vitro","volume":"91","author":"Sane","year":"2019","journal-title":"J. Med Virol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"495","DOI":"10.4155\/fmc-2015-0019","article-title":"SAR evolution and discovery of benzenesulfonyl matrinanes as a novel class of potential coxsakievirus inhibitors","volume":"8","author":"Tang","year":"2016","journal-title":"Futur. Med. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.antiviral.2015.09.009","article-title":"Molecular mechanism of a specific capsid binder resistance caused by mutations outside the binding pocket","volume":"123","author":"Braun","year":"2015","journal-title":"Antivir. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11892-016-0819-2","article-title":"MicroRNAs in Type 1 Diabetes: Complex Interregulation of the Immune System, \u03b2 Cell Function and Viral Infections","volume":"16","author":"Isaacs","year":"2016","journal-title":"Curr. Diabetes Rep."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1007\/s00018-017-2567-0","article-title":"Persistent coxsackievirus B4 infection induces microRNA dysregulation in human pancreatic cells","volume":"74","author":"Engelmann","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1080\/21505594.2017.1284735","article-title":"Persistence of Coxsackievirus B4 in pancreatic ductal-like cells results in cellular and viral changes","volume":"8","author":"Alidjinou","year":"2017","journal-title":"Virulence"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1080\/1040841X.2018.1499608","article-title":"miRNAs in enterovirus infection","volume":"44","author":"Engelmann","year":"2018","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.1178178","article-title":"Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection","volume":"327","author":"Lanford","year":"2010","journal-title":"Science"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV Infection by Targeting MicroRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Ye, X., Liu, Z., Hemida, M., and Yang, D. (2011). Targeted Delivery of Mutant Tolerant Anti-Coxsackievirus Artificial MicroRNAs Using Folate Conjugated Bacteriophage Phi29 pRNA. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0021215"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e94387","DOI":"10.1172\/jci.insight.94387","article-title":"An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes","volume":"2","author":"Levet","year":"2017","journal-title":"JCI Insight"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Dechaumes, A., Bertin, A., Sane, F., Levet, S., Varghese, J., Charvet, B., Gmyr, V., Kerr-Conte, J., Pierquin, J., and Arunkumar, G. (2020). Coxsackievirus-B4 Infection Can Induce the Expression of Human Endogenous Retrovirus W in Primary Cells. Microorganisms, 8.","DOI":"10.3390\/microorganisms8091335"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11892-019-1256-9","article-title":"Human Endogenous Retroviruses and Type 1 Diabetes","volume":"19","author":"Levet","year":"2019","journal-title":"Curr. Diabetes Rep."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s00125-016-4201-3","article-title":"Interferon-\u03b1 mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes","volume":"60","author":"Marroqui","year":"2017","journal-title":"Diabetologia"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Akhbari, P., Richardson, S.J., and Morgan, N.G. (2020). Type 1 Diabetes: Interferons and the Aftermath of Pancreatic Beta-Cell Enteroviral Infection. Microorganisms, 8.","DOI":"10.3390\/microorganisms8091419"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"eabd6527","DOI":"10.1126\/sciadv.abd6527","article-title":"Islet expression of type I interferon response sensors is associated with immune infiltration and viral infection in type 1 diabetes","volume":"7","author":"Apaolaza","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni771","article-title":"Target cell defense prevents the development of diabetes after viral infection","volume":"3","author":"Maday","year":"2002","journal-title":"Nat. Immunol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.virol.2007.05.010","article-title":"Interferons induce an antiviral state in human pancreatic islet cells","volume":"367","author":"Hultcrantz","year":"2007","journal-title":"Virology"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"12439","DOI":"10.1073\/pnas.0806439105","article-title":"Interferon-\u03b1 initiates type 1 diabetes in nonobese diabetic mice","volume":"105","author":"Li","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaut.2017.02.002","article-title":"Interferon alpha impairs insulin production in human beta cells via endoplasmic reticulum stress","volume":"80","author":"Lombardi","year":"2017","journal-title":"J. Autoimmun."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1038\/s41467-020-16327-0","article-title":"An integrated multi-omics approach identifies the landscape of interferon-\u03b1-mediated responses of human pancreatic beta cells","volume":"11","author":"Colli","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1128\/AAC.01073-16","article-title":"In Vitro Assessment of Combinations of Enterovirus Inhibitors against Enterovirus 71","volume":"60","author":"Wang","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/med.21664","article-title":"Medicinal chemistry strategies toward host targeting antiviral agents","volume":"40","author":"Ji","year":"2020","journal-title":"Med. Res. Rev."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12929-021-00708-8","article-title":"Antivirals blocking entry of enteroviruses and therapeutic potential","volume":"28","author":"Anasir","year":"2021","journal-title":"J. Biomed. Sci."}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/10\/4\/768\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:48:45Z","timestamp":1760136525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/10\/4\/768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":96,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["microorganisms10040768"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms10040768","relation":{},"ISSN":["2076-2607"],"issn-type":[{"type":"electronic","value":"2076-2607"}],"subject":[],"published":{"date-parts":[[2022,4,1]]}}}